George Washington University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, George Washington University sits in the top decile of US sponsors by registered trial count (#208 of 15,742 sponsors by registered trial count).
George Washington University: 133 sponsored US clinical trials, 24 recruiting.
George Washington University sponsors 133 registered US clinical trials on ClinicalTrials.gov, 24 of them currently recruiting, and 88 completed. 11 of these trials are in Phase 3-4 (later-stage) and 18 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Postpartum Hemorrhage, with 2 trials.
Top-decile sponsor footprint
George Washington University ranks in the top decile of sponsors by registered trial count (#208 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
88 of 102 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
133 total, page 3 of 3
Evaluating Cancer Survivorship Care Models
NCT02362750
SmokefreeMOM: Reaching Pregnant Smokers With Health Information Via Text Messaging
NCT02412956
Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy
NCT01982383
Effect of Hand-off Skills Training for Students During the Medicine Clerkship
NCT02217241
Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study
NCT01393782
Antimicrobial Stewardship Through MRSA Diagnosis in Emergency Department (ED) Patients With Abscesses
NCT01523899
Wound Etiology and Healing Study
NCT01352078
The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer
NCT01351844
H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department
NCT01376414
Nutrient Timing Following Resistance Exercise
NCT01674049
Community Healthcare for Asthma Management and Prevention of Symptoms
NCT02454192
Epidural Contrast Flow Patterns of TESI Using the Inferior-Anterior Position as the Final Needle Tip Position.
NCT01836770
The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System
NCT01206933
Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis
NCT01019200
A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis
NCT00930384
Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals
NCT01381029
A Study To Examine Serologic Response In Hospitalized Patients Receiving Polyvalent Pneumococcal Vaccine
NCT00955851
Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection
NCT01084954
Diabetes Scorecard Educational Intervention Study
NCT01339520
Safety and Dose Finding Study of Xigris in Hemodialysis Patients
NCT01227187
Prevention of Postoperative Atrial Fibrillation
NCT01742039
Protocol to Assess the Severity of Acute Kidney Injury
NCT00673244
A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure
NCT00662753
Membrane Sweeping in Group B Streptococcus (GBS) Positive Patients
NCT01180023
Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals
NCT00632970
Detection of Chemotherapy Induced Cardiotoxicity
NCT00636844
Genotypic and Phenotypic Correlates of Resistance to Aspirin
NCT01361620
CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study
NCT00522002
Maternal Oxygen Use During Delivery and Cord Blood Superoxide Dismutase
NCT01042262
Enhancing Empathy in Medical Communication Through Perspective-Taking
NCT00861991
Prospective Investigation of Pulmonary Embolism Diagnosis III
NCT00241826
Lamictal in the Treatment of Post-Herpetic Neuralgia
NCT00295776
Effects of Massage Therapy and Kinesthetic Stimulation on Pre-Term Infants
NCT00661791
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 11 |
| Phase 2 | 7 |
| Phase 3 | 1 |
| Phase 4 | 10 |
What is open in the George Washington University pipeline
24 recruiting of 133 indexed (18% open); 88 completed (66%).
Phase mix: 11 late (III/IV) vs 18 early (I/II) (early-phase heavy).
Top condition: Postpartum Hemorrhage (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
George Washington University: open-pipeline peers nationwide
Peers matched on 133 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
George Washington University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 133 trials (± recruiting share)
- Millennium Pharmaceuticals · 135 trials · 0% recruiting
- National Institute on Aging (NIA) · 131 trials · 9% recruiting
- The Miriam Hospital · 136 trials · 11% recruiting
- Rhode Island Hospital · 130 trials · 20% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- West Virginia University · 18% recruiting · 122 trials
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
Related
What to do with this George Washington University page
133 registered trials is a research-attention snapshot, not an endorsement of George Washington University or any single study.
- 24 of George Washington University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Postpartum Hemorrhage is the condition George Washington University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Postpartum Hemorrhage trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. George Washington University pipeline card: 133 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.